Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.5798
-0.0292 (-4.79%)
At close: Jan 30, 2026
Vaxart Employees
Vaxart had 105 employees as of December 31, 2024. The number of employees decreased by 4 or -3.67% compared to the previous year.
Employees
105
Change (1Y)
-4
Growth (1Y)
-3.67%
Revenue / Employee
$1,411,467
Profits / Employee
-$482,886
Market Cap
139.14M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 105 | -4 | -3.67% |
| Dec 31, 2023 | 109 | -55 | -33.54% |
| Dec 31, 2022 | 164 | 54 | 49.09% |
| Dec 31, 2021 | 110 | 82 | 292.86% |
| Dec 31, 2020 | 28 | 14 | 100.00% |
| Sep 30, 2020 | 30 | 2 | 7.14% |
| Jun 30, 2020 | 16 | -17 | -51.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
Vaxart News
- 16 days ago - Vaxart (VXRT) Advances Oral Vaccine with Promising Phase 1 Trial Results - GuruFocus
- 22 days ago - Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - GlobeNewsWire
- 2 months ago - Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript - Seeking Alpha
- 2 months ago - Vaxart (VXRT) and Precigen (PGEN) Shares Surge on Strong Q3 Earnings - GuruFocus
- 2 months ago - Vaxart, Precigen among biotech gainers after Q3 results - Seeking Alpha
- 2 months ago - Vaxart Inc (VXRT) Q3 2025 Earnings Call Highlights: Strategic Partnership and Revenue Surge ... - GuruFocus
- 2 months ago - Vaxart (VXRT) Secures $700 Million Partnership with Dynavax - GuruFocus
- 2 months ago - Vaxart extends cash runway into Q2 2027 with Dynavax partnership and targets 2026 data readouts - Seeking Alpha